Nitric oxide and β2-adrenoceptor activation attenuate pulmonary vasoconstriction during anaphylactic hypotension in anesthetized BALB/c mice

Experimental Lung Research

Volumn 39, Issue 3, 2013, Pages 119-129

  Shinomiya, Shohei ^a   Shibamoto, Toshishige ^a   Kurata, Yasutaka ^a   Kuda, Yuhichi ^a   Zhang, Wei ^a,b   Tanida, Mamoru ^a   Toga, Hirohisa ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b QINGHAI UNIVERSITY   (China)

Author keywords

Anaphylaxis; ICI 118,551; L NAME; Pulmonary arterial pressure

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ATENOLOL; BETA 2 ADRENERGIC RECEPTOR; ICI 118 551; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OVALBUMIN; PROSTAGLANDIN SYNTHASE; UNCLASSIFIED DRUG;

AIRWAY PRESSURE; ANAPHYLACTIC HYPOTENSION; ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA FLOW; ARTICLE; BLOOD PRESSURE MEASUREMENT; CENTRAL VENOUS PRESSURE; CONTROLLED STUDY; HEART AFTERLOAD; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG VASOCONSTRICTION; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SYSTOLIC BLOOD PRESSURE; VENOUS RETURN;

ADRENERGIC BETA-ANTAGONISTS; ANAPHYLAXIS; ANIMALS; ATENOLOL; BRONCHOCONSTRICTION; CYCLOOXYGENASE INHIBITORS; ENZYME INHIBITORS; HYPOTENSION; INDOMETHACIN; MALE; MICE; MICE, INBRED BALB C; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PROPANOLAMINES; PULMONARY CIRCULATION; RECEPTORS, ADRENERGIC, BETA-2; VASOCONSTRICTION;

EID: 84875739392     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2013.768720     Document Type: Article

References (41)

1. Brown AF: Anaphylactic shock: mechanisms and treatment. J Accid Emerg Med. 1995;12:89-100.
2. Brown SG: Cardiovascular aspects of anaphylaxis: implications for treatment and diagnosis. Curr Opin Allergy Clin Immunol. 2005;5:359-364.
3. Sampson HA, Muñoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Camargo CA Jr, Cydulka R, Galli SJ, Gidudu J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL, Metcalfe DD, O'Connor R,Muraro A, Rudman A, Schmitt C, Scherrer D, Simons FE, Thomas S, Wood JP, Decker WW: Second symposium on the definition andmanagement of anaphylaxis: summary report-second. National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Ann Emerg Med. 2006;117:391-397.
4. Morel DR, Skoskiewicz M, Robinson DR, Bloch KJ, Hoaglin DC, Zapol WM: Leukotrienes, thromboxane A2, and prostaglandins during systemic anaphylaxis in sheep. Am J Physiol. 1991;261:H782-H792.
5. Smedegard G, Revens B, Lundberg C, Arfors KE: Anaphylactic shock in monkeys passively sensitized with human reaginic serum. I. Hemodynamics and cardiac performance. Acta Physiol Scand. 1981;111:239-247.
6. Silverman HJ, Taylor WR, Smith PL, Kagey-Sobotka A, Permutt S, Lichtenstein LM, Bleecker ER: Effects of antihistamines on the cardiopulmonary changes due to canine anaphylaxis. J Appl Physiol. 1988;64:210-217.
7. Mink SN, Becker A, Unruh H, Kepron W: Effects of anaphylaxis mediators on partitioned pulmonary vascular resistance during ragweed shock in dogs. J Appl Physiol. 1998;84:782-790.
8. Halonen M, Fisher HK, Blair C, Butler C 2nd, Pinckard RN: IgE-induced respiratory and circulatory changes during systemic anaphylaxis in the rabbit. Am Rev Respir Dis. 1976;114:961-970.
9. Zhang W, Shibamoto T, Kuda Y, Ohmukai C, Kurata Y: Pulmonary vasoconstrictive and bronchoconstrictive responses to anaphylaxis are weakened via β2-adrenoceptor activation by endogenous epinephrine in anesthetized rats. Anesthesiology. 2011;114:614-623.
10. Leblais V, Delannoy E, Fresquet F, Bgueret H, Bellance N, Banquet S, Allìeres C, Leroux L, Desgranges C, Gadeau A, Muller B: β-adrenergic relaxation in pulmonary arteries: preservation of the endothelial nitric oxide-dependent β2 component in pulmonary hypertension. Cardiovasc Res. 2008;77: 202-210.
11. Pourageaud F, Leblais V, Bellance N, Marthan R, Muller B: Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.Naunyn Schmiedebergs Arch Pharmacol. 2005;372:14-23.
12. Goldie RG, Paterson JW, Lulich KM: Adrenoceptors in airway smooth muscle. Pharmacol Ther. 1990;48:295-322.
13. Mjrndal TO, Chesrown SE, Frey MJ, Reed BR, Lazarus SC, Gold WM: Effect of beta-adrenergic stimulation on experimental canine anaphylaxis in vivo. J Allergy Clin Immunol. 1983;71:62-70.
14. Silverman HJ, Taylor WR, Smith PL, Kagey-Sobotka A, Lichtenstein LM, Bleecker ER: Prevention of canine anaphylaxis with isoproterenol. Am Rev Respir Dis. 1986;134:243-247.
15. Amir, S., English, A.M.: An inhibitor of nitric oxide production, NG-nitro-L-arginine-methyl ester, improves survival in anaphylactic shock. Eur J Pharmacol. 1991;203:125-127.
16. Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P: Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest. 2006;116:2244-2251.
17. Thiemermann C: Nitric oxide and septic shock. Gen Pharmacol. 1997;29:159-166.
18. Osada S, IchikiH,Oku H, Ishiguro K,KunitomoM, Semma M: Participation of nitric oxide in mouse anaphylactic hypotension. Eur J Pharmacol. 1994;252:347-350.
19. Kelly LJ, Undem BJ, Adams GK 3rd: Endogenous vasodilators modulate pulmonary vascular anaphylaxis. J Appl Physiol. 1994;76:916-922.
20. Daffonchio L, Fano M, Omini C: Rat pulmonary artery responses to some mediators of anaphylaxis: modifications by indomethacin. Pharmacol Res Commun. 1984;16:679-688.
21. Liu W, Takano H, Shibamoto T, Cui S, Zhao ZS, Zhang W, Kurata Y: Involvement of splanchnic vascular bed in anaphylactic hypotension in anesthetized BALB/c mice. Am J Physiol Regul Integr Comp Physiol. 2007;293:R1947-R1953.
22. Cingolani OH, Kass DA: Pressure-volume relation analysis of mouse ventricular function. Am J Physiol Heart Circ Physiol. 2011;301:H2198-H2206.
23. Moore PK, Oluyomi AO, Babbedge RC,Wallace P, Hart SL: LNG-nitro arginine methyl ester exhibits antinociceptive activity in the mouse. Br J Pharmacol. 1991;102:198-202.
24. Rees DD, Palmer RM, Schulz R, Hodson HF, Moncada S: Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990;101:746-752.
25. jrai Z, Wagner JA, Goparaju SK, Wang L, Razdan RK, Sugiura T, Zimmer AM, Bonner TI, Zimmer A, Kunos G: Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice. Hypertension. 2000;35:679-684.
26. Pumphrey RS, Roberts IS: Postmortem findings after fatal anaphylactic reactions. J Clin Pathol. 2000;53:273-276.
27. Brown SG, Mullins RJ, Gold MS: Anaphylaxis: diagnosis and management. Med J Aust. 2006;185:283-289.
28. TakanoH, LiuW, Zhao Z, Cui S, ZhangW, ShibamotoT:NGnitro-L-arginine methyl ester, but not methylene blue, attenuates anaphylactic hypotension in anesthetized mice. J Pharmacol Sci. 2007;104:212-217.
29. Levi R, Gross SS, Lamparter B, Fasehun OA, Aisaka K, Jaffe EA, Griffith OW, Stuehr DJ: Evidence that L-arginine is the biosynthetic precursor of vascular and cardiac nitric oxide. In: Moncada S, and Higgs EA, eds. Nitric Oxide from L-Arginine: A Bioregulatory System. Amsterdam, Netherlands: Elsevier; 1990;35-45.
30. Sakuma I, Gross SS, Levi R: Peptidoleukotrienes induce an endothelium-dependent relaxation of guinea pig main pulmonary artery and thoracic aorta. Prostaglandins. 1987;34:685-696.
31. Kamata K, Mori T, Shigenobu K, Kasuya Y: Endotheliumdependent vasodilator effects of platelet activating factor on rat resistance vessels. Br J Pharmacol. 1989;98:1360-1364.
32. Bakhle YS, Smith TW: Tryptamine receptors in rat pulmonary artery. Br J Pharmacol. 1974;51:459-461.
33. Ahmed T, Marchette B, Wanner A, Yerger L: Direct and indirect effects of leukotriene D4 on the pulmonary and systemic circulations. Am Rev Respir Dis. 1985;131:554-558.
34. Voelkel NF, Stenmark KR, Reeves JT, Mathias MM, Murphy RC: Actions of lipoxygenase products in isolated rat lungs. J Appl Physiol. 1984;57:860-867.
35. Sakai A, Chang SW, Voelkel NF: Importance of vasoconstriction in lipid mediator-induced pulmonary edema. J Appl Physiol. 1989;66:2667-2674.
36. Russell PC, Wright CE, Barer GR, Howard P: Histamine induced pulmonary vasodilatation in the rat: site of action and changes in chronic hypoxia. Eur Respir J. 1994;7: 1138-1144.
37. Held HD, Martin C, Uhlig S: Characterization of airway and vascular responses in murine lungs. Br J Pharmacol. 1999;126:1191-1199.
38. West JB, Dollery CT, Naimark A: Distribution of blood flow in isolated lung; relation to vascular and alveolar pressures. J Appl Physiol. 1964;19:713-724.
39. Weissmann N, Akkayagil E, Quanz K, Schermuly RT, Ghofrani HA, Fink L, Hnze J, Rose F, Seeger W, Grimminger F: Basic features of hypoxic pulmonary vasoconstriction in mice. Respir Physiol Neurobiol. 2004;139:191-202.
40. Miyahara T, Shibamoto T, Wang HG, Koyama S: Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs. J Appl Physiol. 1997;83:1508-1516.
41. Enzan K, Shouji K, Inaba H, Yoshioka N: Inhibition of pulmonary hypertensive response after antigen challenge. Shock. 1995;4:294-297.